CacheBy
ELK Biotechnology Lamin A/C (phospho Ser392) rabbit pAb
원본

ELK Biotechnology Lamin A/C (phospho Ser392) rabbit pAb

상품 한눈에 보기

Lamin A/C 단백질의 Ser392 인산화 부위를 인식하는 토끼 폴리클로날 항체로, WB, IHC, IF, ELISA에 적합합니다. 핵막 및 라미나 연구에 활용되며, 인간, 마우스, 랫트 시료에 반응합니다. -20°C에서 1년간 안정적으로 보관 가능합니다.

판매단위
pk
카탈로그 보기

카탈로그

2개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
ELK Biotechnology ES6125-100UL Lamin A/C (phospho Ser392) rabbit pAb, 100UL pk판매 단위 pk ·
재고 확인 필요
402,000원VAT 포함 442,200원
ELK Biotechnology ES6125-50UL Lamin A/C (phospho Ser392) rabbit pAb, 50UL pk판매 단위 pk ·
재고 확인 필요
301,000원VAT 포함 331,100원

ELK Biotechnology · ELK Biotechnology Lamin A/C (phospho Ser392) rabbit pAb

제품명

Lamin A/C (phospho Ser392) rabbit pAb

제품 정보

항목 내용
Alternative Names LMNA; LMN1; Prelamin-A/C
Applications WB; IHC; IF; ELISA
Recommended Dilutions WB: 1/500–1/2000
IHC: 1/100–1/300
IF: 1/200–1/1000
ELISA: 1/10000
Not yet tested in other applications
Immunogen Synthesized peptide derived from human Lamin A/C around phosphorylation site of Ser392 (AA range: 361–410)
Host Species Rabbit
Storage -20°C, 1 year
Clonality Polyclonal
Isotype IgG
Concentration 1 mg/ml
Observed Band 74 kDa
Gene ID (Human) 4000
Human Swiss-Prot No. P02545
Species Reactivity Human; Mouse; Rat

세포 내 위치

Nucleus, nuclear envelope, nuclear lamina, nucleoplasm, and nucleus matrix.
Farnesylation of prelamin-A/C facilitates nuclear envelope targeting and subsequent cleavage by ZMPSTE24/FACE1 to remove the farnesyl group, producing mature lamin-A/C that integrates into the nuclear lamina.
EMD is required for proper localization of non-farnesylated prelamin-A/C.
Isoform C: localized in nucleus speckle.

배경 (Background)

Lamin A/C (LMNA) is a component of the nuclear lamina, a protein matrix adjacent to the inner nuclear membrane. Lamin proteins are evolutionarily conserved and play key roles in nuclear stability, chromatin organization, and gene expression.
During mitosis, lamins are phosphorylated, leading to reversible disassembly of the lamina. Vertebrate lamins are classified into A and B types, with LMNA encoding multiple transcript variants via alternative splicing.
Mutations in LMNA are associated with several diseases, including Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb-girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome.
(RefSeq, Apr 2012)

ELK Biotechnology 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.